All IBS pts filled out a Visual Analogic Scale (VAS) score to evaluate symptoms (abdominal pain, constipation, diarrhoea, bloating, flatulence) at time zero and 1 month after the treatment.

Background: The aim of this study was to develop and psychometrically test a short, patient-reported questionnaire to be used in clinical practice for patients with Irritable Bowel Syndrome (IBS).

When the researchers then examined how well the participants responded to the treatments, using an established IBS symptom ...

EnteroBiotix's IBS trial is the company's second to suggest there is value in the approach, coming a few months after the ...

A novel IgG-guided elimination diet shows potential in reducing abdominal pain in patients with irritable bowel syndrome. Read now.

PETALING JAYA: Property developer S P Setia Bhd has achieved a record-breaking industrialised building system (IBS) score of 93.95 by the Construction Industry Development Board for more than ...

Glasgow, Scotland Wednesday, March 19, 2025, 09:00 Hrs [IST] ...

EnteroBiotix Announces Positive Topline Phase 2a Results with EBX-102-02, a Potential First-in-Class Treatment for Irritable Bowel Syndrome (IBS) EBX-102-02 demonstrated clinically meaningful ...